| RS1602431663 |
CASK
|
Health Risk |
Pathogenic |
— |
| RS1602439597 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS1602439611 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS1602439662 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS1602442819 |
PHEX
|
Health Risk |
Likely pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS1602442871 |
PHEX
|
Health Risk |
Likely pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS1602446549 |
ARHGEF9
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 8 |
| RS1602451773 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1602454605 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1602454639 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1602454747 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1602455302 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1602455747 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1602456175 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1602456486 |
DMD
|
Health Risk |
Pathogenic/Likely pathogenic |
Duchenne muscular dystrophy, Becker muscular dystrophy |
| RS1602456821 |
COL18A1
|
Health Risk |
Pathogenic |
Knobloch syndrome, Knobloch syndrome |
| RS1602459252 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1602459861 |
DMD
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1602460062 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1602467530 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1602467590 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1602467787 |
DMD
|
Health Risk |
Pathogenic/Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1602468968 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1602469251 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1602469384 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1602481623 |
TAF1
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked |
| RS1602485677 |
MORC2
|
Health Risk |
Likely pathogenic |
— |
| RS1602485728 |
MORC2
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease axonal type 2Z |
| RS1602485958 |
MORC2
|
Health Risk |
Likely pathogenic |
— |
| RS1602489684 |
TAF1
|
Health Risk |
Likely pathogenic; association |
Intellectual disability, X-linked |
| RS1602490113 |
TAF1
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked |
| RS1602491118 |
ARHGEF9
|
Health Risk |
Pathogenic |
— |
| RS1602491207 |
HDAC8
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 1, Cornelia de Lange syndrome 1 |
| RS1602496057 |
MORC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease axonal type 2Z, Developmental delay |
| RS1602499631 |
MORC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2Z, Charcot-Marie-Tooth disease axonal type 2Z |
| RS1602499659 |
MORC2
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease axonal type 2Z, Charcot-Marie-Tooth disease axonal type 2Z |
| RS1602506017 |
TAF1
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked |
| RS1602510200 |
MORC2
|
Health Risk |
Pathogenic |
Developmental delay, impaired growth |
| RS1602510214 |
MORC2
|
Health Risk |
Likely pathogenic |
Developmental delay, impaired growth |
| RS1602510452 |
TUBGCP6
|
Health Risk |
Likely pathogenic |
Microcephaly and chorioretinopathy 1, Microcephaly and chorioretinopathy 1 |
| RS1602511836 |
LOC101928335;MID2
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 101 |
| RS1602520317 |
TAF1
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked |
| RS1602532154 |
LAMP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Danon disease, Cardiovascular phenotype |
| RS1602534094 |
USP18
|
Health Risk |
Pathogenic/Likely pathogenic |
Pseudo-TORCH syndrome 2, Pseudo-TORCH syndrome 2 |
| RS1602534666 |
LAMP2
|
Health Risk |
Likely pathogenic |
— |
| RS1602535807 |
LAMP2
|
Health Risk |
Likely pathogenic |
— |
| RS1602537159 |
WDR45
|
Health Risk |
Pathogenic |
Neurodegeneration with brain iron accumulation 5, Neurodegeneration with brain iron accumulation 5 |
| RS1602537729 |
WDR45
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodegeneration with brain iron accumulation 5, Neurodegeneration with brain iron accumulation 5 |
| RS1602537958 |
WDR45
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, Neurodegeneration with brain iron accumulation 5 |
| RS1602538023 |
WDR45
|
Health Risk |
Likely pathogenic |
Neurodegeneration with brain iron accumulation 5, Neurodegeneration with brain iron accumulation 5 |
| RS1602538148 |
WDR45
|
Health Risk |
Pathogenic |
Neurodegeneration with brain iron accumulation 5, Neurodegeneration with brain iron accumulation 5 |
| RS1602538353 |
TAF1
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked |
| RS1602538372 |
WDR45
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodegeneration with brain iron accumulation 5, Neurodegeneration with brain iron accumulation 5 |
| RS1602538379 |
WDR45
|
Health Risk |
Pathogenic |
Neurodegeneration with brain iron accumulation 5, Neurodegeneration with brain iron accumulation 5 |
| RS1602538385 |
WDR45
|
Health Risk |
Likely pathogenic |
Neurodegeneration with brain iron accumulation 5, Neurodegeneration with brain iron accumulation 5 |
| RS1602539140 |
WDR45
|
Health Risk |
Pathogenic |
Neurodegeneration with brain iron accumulation 5, Neurodegeneration with brain iron accumulation 5 |
| RS1602539322 |
WDR45
|
Health Risk |
Likely pathogenic |
Neurodegeneration with brain iron accumulation 5, Neurodegeneration with brain iron accumulation 5 |
| RS1602540060 |
WDR45
|
Health Risk |
Likely pathogenic |
Neurodegeneration with brain iron accumulation 5, Neurodegeneration with brain iron accumulation 5 |
| RS1602540152 |
LAMP2
|
Health Risk |
Pathogenic |
Danon disease, Danon disease |
| RS1602540211 |
WDR45
|
Health Risk |
Pathogenic |
Neurodegeneration with brain iron accumulation 5, Inborn genetic diseases |
| RS1602540235 |
WDR45
|
Health Risk |
Likely pathogenic |
Seizure, Autism |
| RS1602540295 |
WDR45
|
Health Risk |
Likely pathogenic |
Neurodegeneration with brain iron accumulation 5, Neurodegeneration with brain iron accumulation 5 |
| RS1602540331 |
WDR45
|
Health Risk |
Likely pathogenic |
Neurodegeneration with brain iron accumulation 5, Neurodegeneration with brain iron accumulation 5 |
| RS1602540581 |
WDR45
|
Health Risk |
Pathogenic |
Dystonic disorder, Basal ganglia calcification |
| RS1602540595 |
WDR45
|
Health Risk |
Pathogenic |
Neurodegeneration with brain iron accumulation 5, Neurodegeneration with brain iron accumulation 5 |
| RS1602544454 |
XIAP
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked lymphoproliferative disease due to XIAP deficiency, See cases |
| RS1602544507 |
XIAP
|
Health Risk |
Pathogenic |
X-linked lymphoproliferative disease due to XIAP deficiency, X-linked lymphoproliferative disease due to XIAP deficiency |
| RS1602546782 |
XIAP
|
Health Risk |
Pathogenic |
X-linked lymphoproliferative disease due to XIAP deficiency, X-linked lymphoproliferative disease due to XIAP deficiency |
| RS1602550687 |
CASK
|
Health Risk |
Likely pathogenic |
Syndromic X-linked intellectual disability Najm type, Syndromic X-linked intellectual disability Najm type |
| RS1602556716 |
RBM10
|
Health Risk |
Likely pathogenic |
— |
| RS1602560972 |
CASK
|
Health Risk |
Pathogenic |
Syndromic X-linked intellectual disability Najm type, Syndromic X-linked intellectual disability Najm type |
| RS1602562990 |
XIAP
|
Health Risk |
Pathogenic |
X-linked lymphoproliferative disease due to XIAP deficiency, X-linked lymphoproliferative disease due to XIAP deficiency |
| RS1602564282 |
EDA
|
Health Risk |
Likely pathogenic |
— |
| RS1602566823 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1602567594 |
CUL4B
|
Health Risk |
Pathogenic |
CUL4B-related disorder, CUL4B-related disorder |
| RS1602572645 |
TAF1
|
Health Risk |
Likely pathogenic; association |
Intellectual disability, X-linked |
| RS1602573558 |
CUL4B
|
Health Risk |
Pathogenic |
— |
| RS1602577238 |
CUL4B
|
Health Risk |
Pathogenic |
X-linked intellectual disability Cabezas type, X-linked intellectual disability Cabezas type |
| RS1602577529 |
ARHGEF9
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 8 |
| RS1602581162 |
GPC3
|
Health Risk |
Pathogenic |
Wilms tumor 1, Wilms tumor 1 |
| RS1602582207 |
RBM10
|
Health Risk |
Pathogenic |
— |
| RS1602582334 |
RBM10
|
Health Risk |
Pathogenic |
TARP syndrome, Nonpapillary renal cell carcinoma |
| RS1602595101 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1602595136 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1602600445 |
PCDH19
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 9 |
| RS1602600561 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1602612611 |
LAS1L
|
Health Risk |
Likely pathogenic |
Wilson-Turner syndrome, Wilson-Turner syndrome |
| RS1602614385 |
EDA
|
Health Risk |
Pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Hypohidrotic X-linked ectodermal dysplasia |
| RS1602614410 |
EDA
|
Health Risk |
Likely pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Hypohidrotic X-linked ectodermal dysplasia |
| RS1602618255 |
EDA
|
Health Risk |
Pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Hypohidrotic X-linked ectodermal dysplasia |
| RS1602618398 |
EDA
|
Health Risk |
Pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Hypohidrotic X-linked ectodermal dysplasia |
| RS1602618442 |
EDA
|
Health Risk |
Pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Hypohidrotic X-linked ectodermal dysplasia |
| RS1602621312 |
CACNA1F
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital stationary night blindness, Congenital stationary night blindness |
| RS1602622972 |
EDA
|
Health Risk |
Pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Hypohidrotic X-linked ectodermal dysplasia |
| RS1602624745 |
EDA
|
Health Risk |
Likely pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Hypohidrotic X-linked ectodermal dysplasia |
| RS1602624914 |
TAF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Marfanoid habitus and intellectual disability, Intellectual disability |
| RS1602624950 |
TAF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, X-linked |
| RS1602625000 |
EDA
|
Health Risk |
Likely pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Hypohidrotic X-linked ectodermal dysplasia |
| RS1602627593 |
CACNA1F
|
Health Risk |
Likely pathogenic |
Congenital stationary night blindness, Congenital stationary night blindness |
| RS1602628429 |
CACNA1F
|
Health Risk |
Likely pathogenic |
Congenital stationary night blindness, Congenital stationary night blindness |